Side of Logo AETC National Resource Center Home Side of Logo Top of Banner
Search Web site
Spacer
space space
Home > Reference Material > Journal Scan
space
space
space

Journal Scan
This page lists Journal Scan articles by topic. You may also view articles by date .
space

Adherence to Antiretroviral Therapy
bullet Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Clin Infect Dis 2003 Oct 15;37(8):1112-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet High levels of adherence do not prevent accumulation of HIV drug resistance mutations. Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. AIDS 2003 Sep 5;17(13):1925-32.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

African Americans
bullet HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Jun 24;52(24):597-601.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Women, inequality, and the burden of HIV. Ojikutu BO, Stone VE. N Engl J Med 2005 Feb 17;352(7):649-52.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV transmission among black women--North Carolina, 2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Feb 4;54(4):89-94.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV transmission among black college student and non-student men who have sex with men--North Carolina, 2003. MMWR Morb Mortal Wkly Rep 2004 Aug 20;53(32):731-4.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Antiretroviral Drug Resistance
bullet The New York case: lessons being learned. Volberding PA. Ann Intern Med 2005 May 17;142(10):866-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The prevalence of antiretroviral drug resistance in the United States. Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA. AIDS 2004 Jul 2;18(10):1393-401.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma JG, Douglas JM, LaLota M, Dickinson G, Schwarcz S, Torian L, Wendell D, Paul S, Goza GA, Ruiz J, Boyett B, Kaplan JE. J Infect Dis 2004 Jun 15;189(12):2174-80.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? Smith DE, Walker BD, Cooper DA, Rosenberg ES, Kaldor JM. AIDS 2004 Mar 26;18(5):709-18.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV drug resistance. Clavel F, Hance AJ. N Engl J Med 2004 Mar 4;350(10):1023-35.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Clin Infect Dis 2003 Oct 15;37(8):1112-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet High levels of adherence do not prevent accumulation of HIV drug resistance mutations. Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. AIDS 2003 Sep 5;17(13):1925-32.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Antiretroviral Therapy
bullet Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK, Study 934 Group. N Engl J Med 2006 Jan 19;354(3):251-60.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Medicare part D and antiretroviral therapy: issues for HIV clinicians. Cheever LW, Vienna MR. Top HIV Med ;13(4):122-4.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. Lawn SD, Bekker LG, Wood R. AIDS 2005 Jul 22;19(11):1113-1124.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. Calza L, Manfredi R, Colangeli V, Tampellini L, Sebastiani T, Pocaterra D, Chiodo F. AIDS 2005 Jul 1;19(10):1051-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Trends in Antiretroviral Therapy Use and Survival Rates for a Large Cohort of HIV-Infected Children and Adolescents in the United States, 1989-2001. McConnell MS, Byers RH, Frederick T, Peters VB, Dominguez KL, Sukalac T, Greenberg AE, Hsu HW, Rakusan TA, Ortiz IR, Melville SK, Fowler MG, for the Pediatric Spectrum of HIV Disease Consortium. J Acquir Immune Defic Syndr 2005 Apr 1;38(4):488-494.
Includes commentary or emphasis by Arthur Ammann, MD.
space
bullet Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Hamill RJ. AIDS 2005 Mar 4;19(4):399-406.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Risk factors for in utero and intrapartum transmission of HIV. Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. J Acquir Immune Defic Syndr 2005 Jan 1;38(1):87-95.
Includes commentary or emphasis by Arthur Ammann, MD.
space
bullet The case for earlier treatment of HIV infection. Holmberg SD, Palella FJ, Lichtenstein KA, Havlir DV. Clin Infect Dis 2004 Dec 1;39(11):1699-704.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Antiretroviral therapy: the "when to start" debates. Cohen CJ, Boyle BA. Clin Infect Dis 2004 Dec 1;39(11):1705-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P, Jung C, Mahamat A, Lang JM, Costagliola D. AIDS 2004 Oct 21;18(15):2029-38.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA 3rd, Acosta EP, Schackman BR, Pilcher CD, Murphy RL, Maher WE, Witt MD, Reichman RC, Snyder S, Klingman KL, Kuritzkes DR; AIDS Clinical Trials Group Study A5095 Team. N Engl J Med 2004 Apr 29;350(18):1850-61.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV drug resistance. Clavel F, Hance AJ. N Engl J Med 2004 Mar 4;350(10):1023-35.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dube MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS; AIDS Clinical Trials Group 384 Team. N Engl J Med 2003 Dec 11;349(24):2293-303.
space
space

Case Finding
bullet HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Jun 24;52(24):597-601.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The New York case: lessons being learned. Volberding PA. Ann Intern Med 2005 May 17;142(10):866-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV transmission among black women--North Carolina, 2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Feb 4;54(4):89-94.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Assessment of increase in perinatal exposure to HIV among Hispanics--20 counties, Georgia, 1994-2002. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2004 Oct 15;53(40):944-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Increases in HIV diagnoses--29 States, 1999-2002. MMWR Morb Mortal Wkly Rep 2003 Nov 28;52(47):1145-8.
space
space

Clinical Manifestations of HIV
bullet Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Hamill RJ. AIDS 2005 Mar 4;19(4):399-406.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ. J Natl Cancer Inst 2004 Jul 21;96(14):1070-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Clinical Trials and Research
bullet Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK, Study 934 Group. N Engl J Med 2006 Jan 19;354(3):251-60.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. J Infect Dis 2005 Jan 15;191(2):150-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ. J Natl Cancer Inst 2004 Jul 21;96(14):1070-6.
Includes commentary or emphasis by .
space
space

Cultural Competency
bullet Improving health care for the lesbian and gay communities. Makadon HJ. N Engl J Med 2006 Mar 2;354(9):895-7.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Drug-Drug Interactions
bullet Oral erythromycin and the risk of sudden death from cardiac causes. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. N Engl J Med 2004 Sep 9;351(11):1089-96.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Education and Training
bullet Hard-to-reach providers: targeted HIV education by the national AIDS education and training centers. Bradley-Springer L, Vojir C, Messeri P. J Assoc Nurses AIDS Care ;14(6):25-36.
space
space

Epidemiology
bullet HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. Backus LI, Boothroyd D, Deyton LR. AIDS 2005 Oct;19 Suppl 3:S13-9.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Jun 24;52(24):597-601.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Women, inequality, and the burden of HIV. Ojikutu BO, Stone VE. N Engl J Med 2005 Feb 17;352(7):649-52.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV transmission among black women--North Carolina, 2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Feb 4;54(4):89-94.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Assessment of increase in perinatal exposure to HIV among Hispanics--20 counties, Georgia, 1994-2002. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2004 Oct 15;53(40):944-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV transmission among black college student and non-student men who have sex with men--North Carolina, 2003. MMWR Morb Mortal Wkly Rep 2004 Aug 20;53(32):731-4.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The prevalence of antiretroviral drug resistance in the United States. Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA. AIDS 2004 Jul 2;18(10):1393-401.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma JG, Douglas JM, LaLota M, Dickinson G, Schwarcz S, Torian L, Wendell D, Paul S, Goza GA, Ruiz J, Boyett B, Kaplan JE. J Infect Dis 2004 Jun 15;189(12):2174-80.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Increases in HIV diagnoses--29 States, 1999-2002. MMWR Morb Mortal Wkly Rep 2003 Nov 28;52(47):1145-8.
space
space

Hepatitis Coinfection
bullet HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. Backus LI, Boothroyd D, Deyton LR. AIDS 2005 Oct;19 Suppl 3:S13-9.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group. N Engl J Med 2004 Jul 29;351(5):438-50.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C; AIDS Clinical Trials Group A5071 Study Team. N Engl J Med 2004 Jul 29;351(5):451-9.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Infections
bullet Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC. Clin Infect Dis 2005 Nov 15;41(10):1373-406.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Hamill RJ. AIDS 2005 Mar 4;19(4):399-406.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. J Infect Dis 2005 Jan 15;191(2):150-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ. J Natl Cancer Inst 2004 Jul 21;96(14):1070-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

International
bullet Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. PLoS Med 2005 Nov;2(11):e298.
Includes commentary or emphasis by .
space
bullet How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. Lawn SD, Bekker LG, Wood R. AIDS 2005 Jul 22;19(11):1113-1124.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Micronutrients: current issues for HIV care providers. Tang AM, Lanzillotti J, Hendricks K, Gerrior J, Ghosh M, Woods M, Wanke C. AIDS 2005 Jun 10;19(9):847-61.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Women, inequality, and the burden of HIV. Ojikutu BO, Stone VE. N Engl J Med 2005 Feb 17;352(7):649-52.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. J Infect Dis 2005 Jan 15;191(2):150-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Malignancies
bullet Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ. J Natl Cancer Inst 2004 Jul 21;96(14):1070-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Men Who Have Sex with Men
bullet Improving health care for the lesbian and gay communities. Makadon HJ. N Engl J Med 2006 Mar 2;354(9):895-7.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Case records of the Massachusetts General Hospital. Case 2-2006. A 31-year-old, HIV-positive man with rectal pain. Davis BT, Thiim M, Zukerberg LR. N Engl J Med 2006 Jan 19;354(3):284-9.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC. Clin Infect Dis 2005 Nov 15;41(10):1373-406.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Jun 24;52(24):597-601.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The New York case: lessons being learned. Volberding PA. Ann Intern Med 2005 May 17;142(10):866-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV transmission among black college student and non-student men who have sex with men--North Carolina, 2003. MMWR Morb Mortal Wkly Rep 2004 Aug 20;53(32):731-4.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Mother to Child Transmission
bullet Risk factors for in utero and intrapartum transmission of HIV. Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. J Acquir Immune Defic Syndr 2005 Jan 1;38(1):87-95.
Includes commentary or emphasis by Arthur Ammann, MD.
space
bullet Assessment of increase in perinatal exposure to HIV among Hispanics--20 counties, Georgia, 1994-2002. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2004 Oct 15;53(40):944-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Nutrition and Food Safety
bullet Micronutrients: current issues for HIV care providers. Tang AM, Lanzillotti J, Hendricks K, Gerrior J, Ghosh M, Woods M, Wanke C. AIDS 2005 Jun 10;19(9):847-61.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Opportunistic Infections
bullet How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. Lawn SD, Bekker LG, Wood R. AIDS 2005 Jul 22;19(11):1113-1124.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Hamill RJ. AIDS 2005 Mar 4;19(4):399-406.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Pediatrics
bullet Trends in Antiretroviral Therapy Use and Survival Rates for a Large Cohort of HIV-Infected Children and Adolescents in the United States, 1989-2001. McConnell MS, Byers RH, Frederick T, Peters VB, Dominguez KL, Sukalac T, Greenberg AE, Hsu HW, Rakusan TA, Ortiz IR, Melville SK, Fowler MG, for the Pediatric Spectrum of HIV Disease Consortium. J Acquir Immune Defic Syndr 2005 Apr 1;38(4):488-494.
Includes commentary or emphasis by Arthur Ammann, MD.
space
bullet Risk factors for in utero and intrapartum transmission of HIV. Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. J Acquir Immune Defic Syndr 2005 Jan 1;38(1):87-95.
Includes commentary or emphasis by Arthur Ammann, MD.
space
bullet Assessment of increase in perinatal exposure to HIV among Hispanics--20 counties, Georgia, 1994-2002. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2004 Oct 15;53(40):944-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Policy
bullet Distribution of health care expenditures for HIV-infected patients. Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS. Clin Infect Dis 2006 Apr 1;42(7):1003-10.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Medicare part D and antiretroviral therapy: issues for HIV clinicians. Cheever LW, Vienna MR. Top HIV Med ;13(4):122-4.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

POPULATIONS
bullet HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. Backus LI, Boothroyd D, Deyton LR. AIDS 2005 Oct;19 Suppl 3:S13-9.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Postexposure Prevention
bullet Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, Cheever L, Johnson M, Paxton LA, Onorato IM, Greenberg AE, U.S. Department of Health and Human Services. MMWR Recomm Rep 2005 Jan 21;54(RR-2):1-20.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Prevention
bullet Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. PLoS Med 2005 Nov;2(11):e298.
Includes commentary or emphasis by .
space
space

Prevention with Positives
bullet The New York case: lessons being learned. Volberding PA. Ann Intern Med 2005 May 17;142(10):866-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The prevalence of antiretroviral drug resistance in the United States. Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA. AIDS 2004 Jul 2;18(10):1393-401.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma JG, Douglas JM, LaLota M, Dickinson G, Schwarcz S, Torian L, Wendell D, Paul S, Goza GA, Ruiz J, Boyett B, Kaplan JE. J Infect Dis 2004 Jun 15;189(12):2174-80.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Primary Care
bullet Distribution of health care expenditures for HIV-infected patients. Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, Stone BK, Carter J, Call S, Pisu M, Allison J, Saag MS. Clin Infect Dis 2006 Apr 1;42(7):1003-10.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Improving health care for the lesbian and gay communities. Makadon HJ. N Engl J Med 2006 Mar 2;354(9):895-7.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Quality of HIV care provided by nurse practitioners, physician assistants, and physicians. Wilson IB, Landon BE, Hirschhorn LR, McInnes K, Ding L, Marsden PV, Cleary PD. Ann Intern Med 2005 Nov 15;143(10):729-36.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE; HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004 Sep 1;39(5):609-29.
space
bullet Combination antiretroviral therapy and the risk of myocardial infarction. Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. N Engl J Med 2003 Nov 20;349(21):1993-2003.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Seniors
bullet Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P, Jung C, Mahamat A, Lang JM, Costagliola D. AIDS 2004 Oct 21;18(15):2029-38.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Side Effects of Antiretroviral Therapy
bullet Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. Calza L, Manfredi R, Colangeli V, Tampellini L, Sebastiani T, Pocaterra D, Chiodo F. AIDS 2005 Jul 1;19(10):1051-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Cardiovascular risk and body-fat abnormalities in HIV-infected adults. Grinspoon S, Carr A. N Engl J Med 2005 Jan 6;352(1):48-62.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J, Cooper DA; Mitochondrial Toxicity Study Group. AIDS 2004 Apr 30;18(7):1029-36.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Grade 4 events are as important as AIDS events in the era of HAART. Reisler RB, Han C, Burman WJ, Tedaldi EM, Neaton JD. J Acquir Immune Defic Syndr 2003 Dec 1;34(4):379-86.
space
bullet Combination antiretroviral therapy and the risk of myocardial infarction. Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. N Engl J Med 2003 Nov 20;349(21):1993-2003.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Starting Antiretroviral Therapy
bullet Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK, Study 934 Group. N Engl J Med 2006 Jan 19;354(3):251-60.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet The case for earlier treatment of HIV infection. Holmberg SD, Palella FJ, Lichtenstein KA, Havlir DV. Clin Infect Dis 2004 Dec 1;39(11):1699-704.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Antiretroviral therapy: the "when to start" debates. Cohen CJ, Boyle BA. Clin Infect Dis 2004 Dec 1;39(11):1705-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P, Jung C, Mahamat A, Lang JM, Costagliola D. AIDS 2004 Oct 21;18(15):2029-38.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA 3rd, Acosta EP, Schackman BR, Pilcher CD, Murphy RL, Maher WE, Witt MD, Reichman RC, Snyder S, Klingman KL, Kuritzkes DR; AIDS Clinical Trials Group Study A5095 Team. N Engl J Med 2004 Apr 29;350(18):1850-61.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dube MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS; AIDS Clinical Trials Group 384 Team. N Engl J Med 2003 Dec 11;349(24):2293-303.
space
space

STI Coinfection
bullet Case records of the Massachusetts General Hospital. Case 2-2006. A 31-year-old, HIV-positive man with rectal pain. Davis BT, Thiim M, Zukerberg LR. N Engl J Med 2006 Jan 19;354(3):284-9.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Symptoms and Syndromes
bullet Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Hamill RJ. AIDS 2005 Mar 4;19(4):399-406.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. J Infect Dis 2005 Jan 15;191(2):150-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

Tuberculosis Coinfection
bullet How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. Lawn SD, Bekker LG, Wood R. AIDS 2005 Jul 22;19(11):1113-1124.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. J Infect Dis 2005 Jan 15;191(2):150-8.
Includes commentary or emphasis by Susa Coffey, MD.
space
space

U.S. Latinos
bullet HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Jun 24;52(24):597-601.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Assessment of increase in perinatal exposure to HIV among Hispanics--20 counties, Georgia, 1994-2002. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2004 Oct 15;53(40):944-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Increases in HIV diagnoses--29 States, 1999-2002. MMWR Morb Mortal Wkly Rep 2003 Nov 28;52(47):1145-8.
space
space

Women
bullet Women, inequality, and the burden of HIV. Ojikutu BO, Stone VE. N Engl J Med 2005 Feb 17;352(7):649-52.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet HIV transmission among black women--North Carolina, 2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2005 Feb 4;54(4):89-94.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Risk factors for in utero and intrapartum transmission of HIV. Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. J Acquir Immune Defic Syndr 2005 Jan 1;38(1):87-95.
Includes commentary or emphasis by Arthur Ammann, MD.
space
bullet Assessment of increase in perinatal exposure to HIV among Hispanics--20 counties, Georgia, 1994-2002. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2004 Oct 15;53(40):944-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
bullet Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ. J Natl Cancer Inst 2004 Jul 21;96(14):1070-6.
Includes commentary or emphasis by Susa Coffey, MD.
space
space
space

Copyright 2010, the AIDS Education & Training Centers National Resource Center, unless otherwise noted. All rights reserved. Email webmaster@aidsetc.org with questions, comments, or problems. See disclaimer for usage guidelines.